Skip to main content

Table 3 Pretreatment patient and disease characteristics

From: Influence of oral glutamine supplementation on survival outcomes of patients treated with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer

Characteristic

All

Glutamine (+)

Glutamine (−)

P-value

 

(N=104)

(N=56)

(N=48)

 

Age (years)

Median (Range)

57.6 (33–69)

58.7 (41–69)

56.5 (33–69)

0.41

Gender (N; %)

Male

67 (64.4)

35 (62.5)

32 (66.7)

0.62

Female

37 (35.6)

21(37.5)

16 (33.3)

 

Histology (N; %)

Squamous cell

64 (61.5)

34 (60.7)

30 (62.5)

0.81

Adeno

40 (38.5)

22 (39.3)

18 (37.5)

 

KPS (N; %)

90 – 100

58 (55.8)

30 (53.6)

28 (58.3)

0.76

70 - 80

46 (44.2)

26 (46.4)

20 (41.7)

 

TN-stage (N; %)

T1N3

7 (6,7)

4 (7,1)

3 (6,3)

0.38

T2N3

13 (12.5)

6 (10.7)

7 (14.5)

 

T3N3

17 (16.3)

10 (17.8)

7 (14.5)

 

T4N0

11 (10.6)

6 (10.7)

5 (10.4)

 

T4N1

16 (15.4)

8 (14.3)

8 (16.7)

 

T4N2

18 (17.3)

10 (17.9)

8 (16.7)

 

T4N3

22 (21.2)

12 (21.5)

10 (20.9)

 

T-stage (N; %)

1

7 (6.7)

4 (7.1)

3 (6.3)

0.33

2

13 (12.5)

6 (10.7)

7 (14.5)

 

3

17 (16.3)

10 (17.8)

7 (14.5)

 

4

67 (64.5)

36 (64.4)

31 (64. 7)

 

N-stage (N; %)

0

11 (10.6)

6 (10.7)

5 (10.4)

0.58

1

16 (15.4)

8 (14.3)

8 (16.7)

 

2

18 (17.3)

10 (17.9)

8 (16.7)

 

3

59 (56.7)

32 (57.1)

25 (58.1)

 

Bulk of T (N; %)

≤ 3.0 cm

8 (7.7)

3 (5.4)

5 (10.4)

0.42

3.01 - 5.0 cm

15 (14.4)

8 (14.3)

7 (14.6)

 

5.01 - 7.0 cm

43 (41.3)

24 (42.9)

19 (39.6)

 

> 7.0 cm

38 (36.6)

21 (37.4)

17 (35.4)

 

Bulk of largest N (N; %)

≤ 2.0 cm

58 (55.8)

30 (53.7)

28 (58.3)

0.22

> 2.0 cm

46 (44.2)

26 (46.3)

20 (41.7)

 

Chemotherapy

Platin – docetaxel

46 (44.2)

24 (42.9)

22 (45.8)

0.79

Platin - vinorelbine

58 (55.8)

32 (57.1)

26 (54.2)

 

Weight (kg)

Median (range)

66.3 (50.5-87.6)

65.9 (50.5-86.8)

67.2 (54.6-87.6)

0.37

BMI (kg/m2)

Median (range)

22.1 (18.4-27.8)

21.8 (18.4-27.6)

22.3 (18.8-27.8)

0.91

  1. Abbreviations: BMI: Body mass index; KPS: Karnofsky performance score; N: Node; T: Tumor.